It is postulated that associations between soy supplements and breast cancer risk or progression may be in part related to the presence of isoflavones, which bind to estrogen receptors and activate estrogen response genes, although the hormone-like effect is much weaker than that of endogenous estradiol or estrone [43]. Here, ESR1 is linked to breast carcinoma.